Topic: Tracking Stocks

SEC hits out at paid-for bioanalysts, CEOs and firms, charges 27

The Securities and Exchange Commission (SEC) has charged 27 companies and individuals over allegations of fraudulent promotion of stocks, as it says it has uncovered a number of writers, sometimes paid by biotech CEOs and comms firms, dressing up unbiased reporting while secretly being paid to tout a company stock.

Biopharma stocks jump as Americans vote for Trump

An audible sigh of relief was heard this morning that, at last, the U.S. 2016 election is over. In the end, in what was an oft-controversial, hot-tempered and at times bewildering contest between two bitter rivals--and in what 18 months ago seemed impossible--Republican Donald Trump has become the president-elect of the United States.